Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Lilly will also continue to offer insulin at no more than $35 per month out-of-pocket, whether a person has commercial insurance or no insurance
This is one of the reasons it is different from GLP-1-only treatments
Finally, I saw this tweet by Nithin Kamath of Zerodha, on how GLP-1 drugs arent selling as planned, and I figured this is a good time to finally write this post: A few months ago, at a party, one of the guests looked unusually thin (and not in a good way - slightly sickly thin)
Check out the full review
GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
If that is on your mind, see our guide on how to prevent and manage facial volume loss while using weight loss injections like semaglutide
